tiprankstipranks
Advertisement
Advertisement
Moderately bullish activity in Hims and Hers Health with shares up 11.29%
PremiumThe FlyModerately bullish activity in Hims and Hers Health with shares up 11.29%
13d ago
Hims and  Hers Health call volume above normal and directionally bullish
Premium
The Fly
Hims and Hers Health call volume above normal and directionally bullish
13d ago
Hims & Hers price target raised to $29 from $25 at Barclays
Premium
The Fly
Hims & Hers price target raised to $29 from $25 at Barclays
14d ago
Notable open interest changes for March 10th
PremiumThe FlyNotable open interest changes for March 10th
14d ago
Novo Nordisk’s Hims deal helps with commercial headwind, says BMO Capital
Premium
The Fly
Novo Nordisk’s Hims deal helps with commercial headwind, says BMO Capital
14d ago
Re-Rating Hims & Hers: Novo Nordisk Partnership De-Risks GLP-1 Exposure and Supports Further Multiple Expansion
Premium
Ratings
Re-Rating Hims & Hers: Novo Nordisk Partnership De-Risks GLP-1 Exposure and Supports Further Multiple Expansion
14d ago
Hims & Hers upgraded to Neutral from Sell at Citi
PremiumThe FlyHims & Hers upgraded to Neutral from Sell at Citi
15d ago
Moderately bullish activity in Hims and Hers Health with shares up 39.33%
Premium
The Fly
Moderately bullish activity in Hims and Hers Health with shares up 39.33%
15d ago
Hims & Hers rises 38.4%
Premium
The Fly
Hims & Hers rises 38.4%
15d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100